Literature DB >> 29249265

Topical Cidofovir for Treatment-Refractory Ocular Surface Squamous Neoplasia.

Matthew H Ip1, C R Robert George2, Zin Naing2, Elliot M Perlman3, William Rawlinson4, Minas T Coroneo5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29249265     DOI： 10.1016/j.ophtha.2017.11.021

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  6 in total

1.  Spontaneous rupture of ocular surface squamous neoplasia-a case report.

Authors:  Jun Hyuk Son; Su-Ho Lim
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

2.  Update on the Management of Ocular Surface Squamous Neoplasia.

Authors:  Umangi Patel; Carol L Karp; Sander R Dubovy
Journal:  Curr Ophthalmol Rep       Date:  2021-02-20

3.  A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.

Authors:  Christine A Kiire; Rosalind M K Stewart; Sathish Srinivasan; Heinrich Heimann; Stephen B Kaye; Baljean Dhillon
Journal:  Eye (Lond)       Date:  2018-12-28       Impact factor: 3.775

Review 4.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

5.  AS-OCT Guided Treatment Of Diffuse Conjunctival Squamous Cell Carcinoma With Resection, Amniotic Membrane Graft And Topical Mitomycin C.

Authors:  Tarek Roshdy Elhamaky; Ahmed Mohammed Elbarky
Journal:  Clin Ophthalmol       Date:  2019-11-20

Review 6.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.